Back
NovoCure Vs. Asensus Surgical Industry Stock Comparison
Sell
43
NVCR
NovoCure
Last Price:
14.18
Seasonality Move:
6.82%
Sell
23
ASXC
Asensus Surgical
Last Price:
0.25
Seasonality Move:
10.66%
Sell
43
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $12.74. The Score for NVCR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Asensus Surgical (ASXC)
is a Sell
Is Asensus Surgical a Buy, Sell or Hold?
- The current Asensus Surgical [ASXC] share price is $0.24. The Score for ASXC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ASXC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
ASXC Stock Price Chart
What is Asensus Surgical's stock price today?
-
The Asensus Surgical share price today is $0.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASXC is experiencing slight selling pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 45.65 | Sell |
| Chaikin Money Flow: | -25256 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.19 - 14.55) | Sell |
| Bollinger Bands (100): | (12.9 - 15.44) | Sell |
ASXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 39.34 | Sell |
| Chaikin Money Flow: | -98212 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.23 - 0.27) | Sell |
| Bollinger Bands (100): | (0.25 - 0.31) | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.36 | Buy |
| 20-day SMA: | 12.98 | Sell |
| 50-day SMA: | 14.23 | Sell |
| 200-day SMA: | 17.26 | Sell |
| 8-day EMA: | 12.52 | Buy |
| 20-day EMA: | 12.92 | Sell |
| 50-day EMA: | 13.7 | Sell |
| 200-day EMA: | 22.33 | Sell |
ASXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.25 | Sell |
| 20-day SMA: | 0.26 | Sell |
| 50-day SMA: | 0.27 | Sell |
| 200-day SMA: | 0.29 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.25 | Sell |
| 50-day EMA: | 0.26 | Sell |
| 200-day EMA: | 0.32 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and a decrease next year of $0.08 per share.
Asensus Surgical Earnings Growth & ASXC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.12 per share, and an increase next year of $0.06 per share.
NovoCure Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Asensus Surgical Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||